1375 A hormone-based bispecific T cell engager (BiTE)-like molecule for the treatment of neuroendocrine tumors

Eleonora Pelle; Mauro Cives; Elliot Medina; Charlotte Mason; Sebastian Snedal; Xiomar Bustos Perez; Leticia Tordesillas; Miguel Gomez Fontela; Renata Rossetti; Gabriele Maiorano; Vincent Luca; Patrick Hwu; Daniel Abate-Daga; Jonathan Strosberg

doi:10.1136/jitc-2022-SITC2022.1375

Article info

PDF

Regular and Young Investigator Award Abstracts

Novel Single-Agent Immunotherapies

1375 A hormone-based bispecific T cell engager (BiTE)-like molecule for the treatment of neuroendocrine tumors

Free

Authors

Eleonora Pelle Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Mauro Cives University of Bari Aldo Moro, Bari, Italy PubMed articles Google scholar articles
Elliot Medina Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Charlotte Mason Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Sebastian Snedal Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Xiomar Bustos Perez Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Leticia Tordesillas Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Miguel Gomez Fontela Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Renata Rossetti Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Gabriele Maiorano National Research Council, Lecce, Italy PubMed articles Google scholar articles
Vincent Luca Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Patrick Hwu Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Daniel Abate-Daga Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Jonathan Strosberg Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles

Citation

Pelle E, Cives M, Medina E, et al

1375 A hormone-based bispecific T cell engager (BiTE)-like molecule for the treatment of neuroendocrine tumors

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.1375

Publication history

First published November 7, 2022.

Online issue publication

November 07, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password